HMGB1 and glioblastoma: TLRs can bind to the released HMGB1 and signal via the NF-κB, pathway causing enhanced production of pro-inflammatory cytokines, exacerbating ROS production in GBM cells [(Galdiero et al., 2013; Gieryng et al., 2017)].